|
|
 |
|
EURX: Eurand Nv Ord - Stock News |
Enter Ticker:
|
|
| Nov 13, 2009 |
EURX: Positive Ph II/III Data w/ZENPEP for Exocrine Pancreatic Insufficiency |
| Nov 13, 2009 |
SmallCapReview.com: Small Cap Stocks to Watch - EURX, VADX, NANO |
| Nov 13, 2009 |
Crown Equity Holdings, Inc.: CRWENews Highlights: EURX, IBM, YGE, TRGL |
| Nov 13, 2009 |
Phase II/III Clinical Study Compares Safety and Efficacy of Two Dosesof ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for FatAbsorption in Adult Chronic Pancreatitis Patients With ExocrinePancreatic Insufficiency |
| Nov 05, 2009 |
Eurand Reports Key Achievements and Strong Revenue Growth for ThirdQuarter 2009 |
| Oct 28, 2009 |
Eurand to Participate in Upcoming Investor Conferences |
| Oct 28, 2009 |
Eurand Completes Public Offering, Including Exercise of theUnderwriters' Over-Allotment Option, for Total Net Proceeds ofApproximately $103.9 Million |
| Oct 23, 2009 |
BiomedReports: News and FDA Updates for Nuvilex (OTC:NVLX), Eurand N.V. (NASDAQ:EURX) |
| Oct 22, 2009 |
Eurand Announces Pricing of Offering of Ordinary Shares |
| Oct 05, 2009 |
Eurand Announces Conference Call on Third Quarter 2009 FinancialResults |
| Sep 30, 2009 |
BiomedReports: News and FDA Updates for Eurand N.V. (NASDAQ:EURX), Kelyniam (OTC:KLYG) |
| Sep 29, 2009 |
Eurand N.V. proposes offering of 2m new shares |
| Sep 28, 2009 |
Eurand Announces Filing of F-3 Registration Statement |
| Sep 17, 2009 |
BiomedReports: News and FDA Updates for Eurand (NASDAQ:EURX), AEterna Zentaris (NASDAQ:AEZS), Keryx (Nasdaq:KERX), Ardea (Nasdaq:RDEA) |
| Sep 16, 2009 |
Eurand to Present at UBS Global Life Sciences Conference |
| |
| ZACKS COMMENTARY FOR EURX |
|
|
|
Sponsored Links 
-0.03